Advertisement
Advertisement
UPC
Universe Pharmaceuticals Inc. Class A Ordinary Shares
1.39
USDSponsored
-0.01
-0.71%
Nov 06, 15:59 UTC -5
Closed
After-Market
1.42
+0.03
+2.09%
Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) Earnings
UPC Earnings Reports
Positive Surprise Ratio
No Data Available for UPC
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Universe Pharmaceuticals Inc. Class A Ordinary Shares earnings per share and revenue
On Jul 20, 2026, UPC reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.52
Actual
$1.75
Surprise
+14.64%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.38
Surprise
+1.04%
Guardian Pharmacy Services, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.30
Actual
$0.33
Surprise
+7.84%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.06
Surprise
+144.90%
Cronos Group Inc. Common Share
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.89
Actual
$1.96
Surprise
+3.17%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.32
Actual
$0.36
Surprise
+9.16%
ARS Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.36
Surprise
-11.15%
Profound Medical Corp. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.21
Surprise
-11.41%
Akebia Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.03
Actual
-$0.04
Surprise
-6.95%
FAQ
What were Universe Pharmaceuticals Inc. Class A Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Universe Pharmaceuticals Inc. Class A Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Universe Pharmaceuticals Inc. Class A Ordinary Shares's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Universe Pharmaceuticals Inc. Class A Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Universe Pharmaceuticals Inc. Class A Ordinary Shares's next earnings report?
Based on --
analysts, Universe Pharmaceuticals Inc. Class A Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.